Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes

NCT: NCT03130244 · ACTIVE_NOT_RECRUITING

NCT IDNCT03130244
StatusACTIVE_NOT_RECRUITING
Start Date2019-09-23
Completion2026-04-30

Brief Summary

Study will monitor changes in HbA1c for subjects in Intervention arm vs control arm.

Frequently Asked Questions

What is Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes?

Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes is a clinical trial registered under NCT03130244. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03130244?

The current status of NCT03130244 (Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes) is: ACTIVE_NOT_RECRUITING.

When did Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes start?

Procedure for Duodenum to Ileal Diversion to Treat Type 2 Diabetes started on 2019-09-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑